Nyxoah (NYXH) Net Income Growth (1y) (2022 - 2026)
Nyxoah (NYXH) Net Income Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.38% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -282.67% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -25.78% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 9.23% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 56.71% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -188.83% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 20.94% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -96.77% |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | -22.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.23% |
| Dec 31, 2025 | 263.50% |
| Sep 30, 2025 | -250.49% |
| Jun 30, 2025 | -68.48% |
| Mar 31, 2025 | 82.71% |
| Dec 31, 2024 | -33.40% |
| Sep 30, 2024 | 273.10% |
| Jun 30, 2024 | -5.68% |
| Mar 31, 2024 | 100.10% |
| Dec 31, 2023 | -194.61% |
| Sep 30, 2023 | -72.06% |
| Jun 30, 2023 | -148.05% |
| Mar 31, 2023 | -172,854.78% |
| Dec 31, 2022 | 216.14% |
| Sep 30, 2022 | 38.80% |
| Jun 30, 2022 | -163.25% |